Home » Topics » Regulatory » Health Canada

Health Canada
RSS

ViaCyte cleared to begin trial of PEC-Direct in U.S. and Canada

May 23, 2017

Health Canada approves Roche's cobas EGFR Mutation Test v2

March 16, 2017

Canada first to approve Kevzara

Feb. 1, 2017

VBI Vaccines cleared to begin phase I study of CMV vaccine candidate in Canada

June 27, 2016

Antibe Therapeutics cleared to begin phase II study of ATB-346

March 7, 2016

Takeda's NDS for ixazomib accepted for priority review in Canada

Feb. 18, 2016

Tobira Therapeutics initiates a program to evaluate cenicriviroc for the treatment of PSC

Jan. 12, 2016

ExCellThera cleared to begin phase I/II trial of ECT-100 for expansion of hematopoietic stem cells

Dec. 23, 2015

Health Canada approves Cingal for osteoarthritis knee pain

Nov. 5, 2015

Xenon initiates phase I trial of XEN-801 for acne

Sep. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...